A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called for an immediate ...

Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

The problematic use of guest editors was spotlighted last week when a genetics journal retracted nearly an entire special ...

Years later, I interned there as a health and science reporter and have since contributed as a freelancer. Reporting on ...

President Trump heralded a drug-pricing agreement with Regeneron, closing the last of 17 deals sought by the White House ...

A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer reception in Europe.

Since I was 7, my goal has been to become a doctor. But life had other plans. I grew up in a blue-collar family in Levittown, ...

In today's Morning Rounds newsletter, a new era in GOP drug policy, an international childhood vaccine campaign grows, and ...

In this week’s STATus Report, host Alex Hogan chats with STAT Washington correspondent Daniel Payne about Trump's ...

WASHINGTON — President Trump heralded a drug pricing agreement with Regeneron on Thursday, closing the last of 17 deals ...

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling ...